Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
Will FDA approve any mRNA vaccine against small-cell lung carcinoma before 2028?
Basic
4
Ṁ205
2027
21%
chance

Resolves YES if the FDA grants full approval for the commercial sale of any mRNA vaccine against small-cell lung carcinoma in the United States before January 1, 2028. This does not include emergency use authorization or other forms of limited authorization. Resolves NO otherwise.

Get
Ṁ1,000
and
S3.00


Sort by:
1y

Is there a particular vaccine in development that you have in mind? A quick google search doesn't suggesting any specific product.

Without knowing anything about a particular product, I'm very bearish on this for many reasons. To name a few:

- SCLC is much less common than NSCLC, so it's not the largest market share

- SCLC, and small-cell cancers in general, are a challenging disease space for drug development. They are historically very treatment-resistant, present few appealing antigenic targets, and many therapies have failed to work there, so it may be easier to show an effective product in other spaces (like NSCLC). This article describes some of the challenges well.

- Arguably, no cancer vaccine has ever been clearly shown to work, despite many attempts. At the academic medical center where I work, for instance, our several attempts to develop cancer vaccines have met with utter failure.

- The only possible exception is the one cancer vaccine that's FDA-approved: sipuleucel T in prostate cancer. I don't have high-level statistics on usage, but general opinion is somewhere between "it literally does nothing" and "it is of modest use in a pretty select group of patients." In my experience it is rarely used.

What is this?

What is Manifold?
Manifold is the world's largest social prediction market.
Get accurate real-time odds on politics, tech, sports, and more.
Win cash prizes for your predictions on our sweepstakes markets! Always free to play. No purchase necessary.
Are our predictions accurate?
Yes! Manifold is very well calibrated, with forecasts on average within 4 percentage points of the true probability. Our probabilities are created by users buying and selling shares of a market.
In the 2022 US midterm elections, we outperformed all other prediction market platforms and were in line with FiveThirtyEight’s performance. Many people who don't like trading still use Manifold to get reliable news.
How do I win cash prizes?
Manifold offers two market types: play money and sweepstakes.
All questions include a play money market which uses mana Ṁ and can't be cashed out.
Selected markets will have a sweepstakes toggle. These require sweepcash S to participate and winners can withdraw sweepcash as a cash prize. You can filter for sweepstakes markets on the browse page.
Redeem your sweepcash won from markets at
S1.00
→ $1.00
, minus a 5% fee.
Learn more.
© Manifold Markets, Inc.Terms + Mana-only TermsPrivacyRules